• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-038
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/04/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It is unknown if the device is returning for analysis.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported on (b)(6) 2025 a 38mm amplatzer septal occluder was selected for implant using a 12f amplatzer trevisio intravascular delivery system to treat an atrial septal defect (asd).The asd was measured 38mm.Sizing was performed with a 34mm amplatzer sizing balloon.The devices were prepared per instructions for use (ifu).Fluoroscopy and transesophageal echocardiogram (tee) were used during the procedure.A stability check was performed.The occluder was implanted.Approximately 24 hours later on transthoracic echocardiogram (tte) the occluder was shown to have embolized in the left ventricle.The patient was transferred to cardiac surgery for removal of the device.The patient did not present with any clinical signs or symptoms.The patient status was stable.
 
Additional Manufacturer Narrative
An event of embolization to the left ventricle was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.There were no complaints associated with any other devices from the lot.Based on the available information, the cause for the reported embolization could not be confirmed.A surgical intervention is a result of case-specific circumstances, a cardiac surgery was performed to remove the device.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23659067
Report Number2135147-2025-06937
Device Sequence Number13275583
Product Code MLV
UDI-Device Identifier00811806010267
UDI-Public(01)00811806010267(17)290228(10)10266106
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number9-ASD-038
Device Catalogue Number9-ASD-038
Device Lot Number10266106
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/04/2025
Supplement Date Received by Manufacturer11/29/2025
Initial Report FDA Received Date11/26/2025
Supplement Report FDA Received Date12/12/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-